Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: An interphase FISH analysis

Pathology and Oncology Research

Volumn 11, Issue 3, 2005, Pages 157-163

  Behjati, Farkhondeh ^a   Atri, Morteza ^a   Najmabadi, Hossein ^b   Nouri, Keramat ^a   Zamani, Mahdi ^a   Mehdipour, Parvin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Breast cancer; Chromosome 1 and 8 aneusomy; Clinicopathological parameters; Interphase FISH; Iranian women; Prognosis

Indexed keywords

CATHEPSIN D; DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHROMOSOME 1; CHROMOSOME 8; CLINICAL ARTICLE; DISOMY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; INVASIVE CARCINOMA; IRAN; MONOSOMY; POLYSOME; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 27644551911     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893392     Document Type: Article

References (41)

1. Adeyinka A, Mertens F, Idvall I, et al: Multiple polysomies in breast carcinoma: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19. Cancer Genet Cytogenet 111: 144-148, 1999.
2. Atri M, Jafarimojarrad E, Javidroozi M, Mehdipour P: Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population. Fam Cancer 2: 117-118, 2003.
3. Bertucci F, Nasser V, Granjeaud S, Houlgatte R: Gene expression profiles of poor prognosis primary breast cancer correlate with survival. Hum Mol Genet 11: 863-872, 2002.
4. Botti C, Pescatore B, Mottolese M, et al: Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue with interphase cytogenetic study. J Am Coll Surg 190: 530-539, 2000.
5. Dies PJV, Baak JPA, Cok PM, et al: Reproducibility of mitosis counting in 2,469 breast cancer specimens. Hum Pathol 23: 603-607, 1992.
6. Dominguez D, Silva J, Silve JM, et al: Clinicopathological characteristics of breast carcinoma with allelic loss in the p73 region. Breast Cancer Res Treat 63: 17-22, 2000.
7. Elston CW: Grading of invasive carcinoma of the breast. In: Diagnostic Histopathology of the Breast. (Eds: Page DL, Anderson TJ), Churchill- Livingstone, Edinburgh, 1987, pp 300-311.
8. Fehm T, Morrison L, Saboorian H, et al: Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 75: 227-239, 2002.
9. Ferti AD, Stamouli MJ, Panani AD, et al: Molecular cytogenetic analysis of breast cancer: a combined multicolour fluorescence in situ hybridization and G-banding study of uncultured tumor cells. Cancer Genet Cytogenet 149: 28-37, 2004.
10. Fitzgibbons PL, Page DL, Weaver D: Prognostic factors in breast cancer, College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978, 2000.
11. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ: Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev 5: 24-27, 2004.
12. Harrison MM, Magee HM, O'loughlin JF: Comparison of chromosome 1 aneusomy detected by interphase cytogenetics and DNA ploidy in carcinoma of the breast. Histopathology 3: 221-226, 1997.
13. th edition. Saunders Company, Philadelphia, 2001, pp 7-25.
14. Hopman AHN, Remaekers FCS, Raap AK, et al: In situ hybridization as a tool to study numeric chromosomal aberrations in solid bladder tumors. Histochemistry 89: 307-316, 1988.
15. Hsu SM, Raine L, Fanger H: Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
16. Hudelist G, Kostler W, Czervenka K, et al: Predicting the clinical course of breast cancer patients undergoing trastuzumab-based therapy: an outlook. Methods Find Exp Clin Pharmacol, 26: 201-210, 2004.
17. Leger I, Thomas M, Ronot X, Brugal G: Detection of chromosome 1 aberration by fluorescent in situ hybridization (FISH) in the human breast cancer cell line MCF-7. Anal Cell Pathol 5: 299-309, 1993.
18. Jain AN, Chin K, Borresen- Dale AL, et al: Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with P53 status and patient survival. Proc Natl Acad Sci 98: 7952-7957, 2001.
19. Kahan E, Ibrahim AS, El Najjar K, et al: Cancer patterns in the Middle East -Special report from the Middle East Cancer Society. Acta Oncol 36: 631-636, 1997.
20. Lalloo F: Genetics for Oncologists. Remedica, London, 2002.
21. Levine AJ: The tumor suppressor genes. Ann Rev Biochem 62: 623-651, 1993.
22. Marinho AF, Botelho M, Schmitt FC: Evaluation of numerical abnormalities of chromosome 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Pathol Res Pract 196: 227-233, 2000.
23. Mark HF, Taylor W, Afify A, et al: Stage I and II infiltrating ductal carcinoma of breast analysed for chromosome 8 copy number using fluorescent in situ hybridization. Pathobiology 65: 184-189, 1997.
24. Massoner A, Augustin F, Duba HC, et al: FISH cytogenetics and prognosis in breast and non-small cell lung cancers. Cytometry 62B: 52-56, 2004.
25. Mehdipour P, Atri M, Jafarimojarrad E, et al: Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pac J Cancer Prev 4: 185-192, 2003.
26. Montazeri A, Ebrahimi M, Mehrdad N, et al. Delayed prevention in breast cancer: A study in Iranian women. BMC Womens Health, 3: 4, 2003.
27. Nakopoulou L, Giannopoulou I, Trafalis D, et al: Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters. Appl Immunohistochem Mol Morphol 10: 20-28, 2002.
28. Nakopoulou L, Tsirmpa I, Giannopoulou I, et al: Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome. Cancer Genet Cytogenet 134: 127-132, 2002.
29. Persons DL, Hartmann LC, Herath JF, et al. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102: 775-779, 1994.
30. Persons DL, Robinson RA, Hsu P, et al. Chromosome specific aneusomy in carcinoma of the breast. Clin Cancer Res 2: 883-888, 1996.
31. Roka S, Fiegl M, Zojer N, et al. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat 48: 125-133, 1998.
32. Santora LM, Mahoney MC, Lawvere S, et al. Breast cancer screening beliefs by practice location. BMC Public Health 3: 9, 2003.
33. Sigurdsson S, Bodvarsdottir SK, Eyfjord J: P53 abnormality and chromosomal instability in the same breast tumor cells. Cancer Genet Cytogenet 12: 150-155, 2000.
34. Summary of Report on Cancer Incidence in Iran. Cancer and Genetics Administration, Non-Communicable Diseases Sector of Iranian Center for Prevention and Control of Diseases. Deputy of Health, Ministry of Health, Treatment and Education, Islamic Republic of Iran, 2000.
35. Takami S, Kawasome C, Kinoshita M, et al: Chromosomal instability detected by fluorescence in situ hybridization in Japanese cancer patients. Clin Chim Acta 308: 127-131, 2001.
36. Truong K, Vielh P, Guilly MN, et al. Quantitative FISH analysis on interphase nuclei may improve diagnosis of DNA diploid breast cancers. Diagn Cytopathol 26: 213-216, 2002.
37. Union International Contre Cancer. TNM classification of International Union Against Cancer. (Eds: Harmanek P, Sobin LH). TNM Atlas, Berlin, Springer-Verlag, 1992.
38. World Health Organization. Histologic typing of breast tumors. In: International Histologic Classification of Tumors. (Eds: Hartman WH, Urello L, Sobin LH, Stalberg H), Geneva, WHO, 1981, pp 15-25.
39. Yamamoto D, Senzaki H, Nakagawa H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer 97: 690-694, 2003.
40. Fan Y-S: Molecular cytogenetics in medicine. In: Methods in Molecular Biology. Vol 204, Molecular Cytogenetics: Protocols and Applications, Humana Press, Totowa, NJ, 2002.
41. Yoshihito U, Mitsuru E, Masataka Y: Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Clin Cancer Res 6: 3193-3198, 2000.